Free Trial

Capital Insight Partners LLC Has $5.63 Million Stock Holdings in Chemed Co. (NYSE:CHE)

Chemed logo with Medical background

Capital Insight Partners LLC grew its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 5.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,633 shares of the company's stock after acquiring an additional 539 shares during the period. Capital Insight Partners LLC owned about 0.07% of Chemed worth $5,633,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. UMB Bank n.a. grew its position in Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Trust Co. of Vermont acquired a new position in Chemed in the 4th quarter worth about $34,000. GAMMA Investing LLC raised its position in Chemed by 60.5% in the third quarter. GAMMA Investing LLC now owns 138 shares of the company's stock valued at $83,000 after purchasing an additional 52 shares during the last quarter. Sound Income Strategies LLC acquired a new stake in shares of Chemed during the third quarter valued at about $201,000. Finally, Farther Finance Advisors LLC lifted its holdings in shares of Chemed by 2,314.3% during the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company's stock worth $203,000 after purchasing an additional 324 shares during the period. Institutional investors own 95.85% of the company's stock.

Insider Buying and Selling at Chemed

In other Chemed news, EVP Spencer S. Lee sold 732 shares of the firm's stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the transaction, the executive vice president now owns 18,287 shares of the company's stock, valued at $10,526,362.94. This trade represents a 3.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Brian C. Judkins acquired 145 shares of the company's stock in a transaction on Monday, December 30th. The stock was acquired at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the purchase, the vice president now owns 1,678 shares of the company's stock, valued at $871,721. This trade represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. 3.32% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms recently commented on CHE. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research note on Saturday, November 30th. Royal Bank of Canada cut their price objective on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 5th.

Get Our Latest Stock Analysis on CHE

Chemed Price Performance

Shares of NYSE:CHE traded up $5.89 during mid-day trading on Wednesday, reaching $563.56. 25,390 shares of the company traded hands, compared to its average volume of 89,790. The firm has a market cap of $8.48 billion, a PE ratio of 28.51, a PEG ratio of 2.19 and a beta of 0.48. The company's 50 day moving average price is $544.14 and its 200-day moving average price is $564.46. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. Chemed's payout ratio is 10.11%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines